StockData

Dyadic International vs Pluri

DYAI and PLUR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DYAI and PLUR compare

Dyadic International and Pluri are about the same size, with market caps of $11.9M and $13.0M.

Pluri grew revenue faster over the last twelve months (10.0% versus −8.0% for Dyadic International).

Dyadic International keeps more of each dollar of sales as profit, with a net margin of −200% compared with −1944% at Pluri.

Dyadic International scores higher on the StockData Score (7 against 4 for Pluri), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDYAIPLUR
Size and price
Market cap$11.9M$13.0M
Share price$0.327$1.05
Change, 1 year−65.3%−76.4%
Change, 5 years−91.5%−95.0%
Beta (5Y)1.180.95
Employees592
StockData Score
Total score7 (better)4
Valuation score1 (better)0
Growth score03 (better)
Performance score11
Health score5 (better)0
Dividend score00
Valuation
P/S3.1× (better)8.9×
FCF yield–−148%
Growth
Revenue growth (TTM)−8.0%10.0% (better)
Revenue growth, 5Y average14.0%–
Profitability
Gross margin16.2%52.0% (better)
Operating margin−195% (better)−2341%
Net margin−200% (better)−1944%
FCF margin–−1318%
Financial health
Interest coverage–−36.8×
Current ratio1.65 (better)0.27
Altman Z-score−22.79 (better)−32.23
Piotroski F-score2 (better)1
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions12.7%0.22%
Held by insiders28.0%54.6%
Insider net buying, 12 months−$125K$1.3M (better)
Short interest, % of float0.32%1.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.